Skip to content

Andreas du Bois

  • PhD, MD
  • Director Dept. Gynecology & Gynecologic Oncology
  • Kliniken Essen Mitte (KEM)
  • 58h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 14297CitationsNumber of citations received by Andreas's publications. Updated daily.

Publications (5)

  • Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer.

    N/AReaders
    N/ACitations
  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

    • Hollestelle A
    • Van Der Baan F
    • Berchuck A
    • et al.
    N/AReaders
    2Citations
    Get full text
  • PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS

    • Southey M
    • Goldgar D
    • Winqvist R
    • et al.
    N/AReaders
    20Citations
    Get full text
  • Identification of six new susceptibility loci for invasive epithelial ovarian cancer

    • Kuchenbaecker K
    • Ramus S
    • Tyrer J
    • et al.
    N/AReaders
    84Citations
    Get full text
  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    • Bojesen S
    • Pooley K
    • Johnatty S
    • et al.
    N/AReaders
    260Citations
    Get full text

Professional experience

Director Dept. Gynecology & Gynecologic Oncology

Kliniken Essen Mitte (KEM)

January 2011 - Present